» Authors » M Wysoczynski

M Wysoczynski

Explore the profile of M Wysoczynski including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 15
Citations 1482
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Kim C, Wu W, Wysoczynski M, Abdel-Latif A, Sunkara M, Morris A, et al.
Leukemia . 2011 Jul; 26(1):106-16. PMID: 21769103
We have observed that conditioning for hematopoietic transplantation by lethal irradiation induces a proteolytic microenvironment in the bone marrow (BM) that activates the complement cascade (CC). As a result, BM...
3.
Ratajczak J, Zuba-Surma E, Klich I, Liu R, Wysoczynski M, Greco N, et al.
Leukemia . 2011 Apr; 25(8):1278-85. PMID: 21483440
A population of CD133(+)Lin(-)CD45(-) very small embryonic/epiblast-like stem cells (VSELs) has been purified by multiparameter sorting from umbilical cord blood (UCB). To speed up isolation of these cells, we employed...
4.
Ratajczak M, Lee H, Wysoczynski M, Wan W, Marlicz W, Laughlin M, et al.
Leukemia . 2010 Apr; 24(5):976-85. PMID: 20357827
The complement cascade (CC) becomes activated and its cleavage fragments play a crucial role in the mobilization of hematopoietic stem/progenitor cells (HSPCs). Here, we sought to determine which major chemoattractant...
5.
Lee H, Wysoczynski M, Liu R, Shin D, Kucia M, Botto M, et al.
Leukemia . 2009 Dec; 24(3):573-82. PMID: 20033053
We reported that complement cascade (CC) becomes activated in bone marrow (BM) during mobilization of hematopoietic stem/progenitor cells (HSPCs) induced by granulocyte colony-stimulating factor (G-CSF) and C5 cleavage has an...
6.
Lee H, Wu W, Wysoczynski M, Liu R, Zuba-Surma E, Kucia M, et al.
Leukemia . 2009 Aug; 23(11):2052-62. PMID: 19657368
We reported that complement cascade (CC) becomes activated in bone marrow (BM) during granulocyte colony-stimulating factor (G-CSF) mobilization of hematopoietic stem/progenitor cells (HSPCs) and showed that, although third CC component...
7.
Shin D, Zuba-Surma E, Wu W, Ratajczak J, Wysoczynski M, Ratajczak M, et al.
Leukemia . 2009 Jul; 23(11):2042-51. PMID: 19641521
Recently, we identified in adult tissues a population of Oct4(+)SSEA-1(+)Sca-1(+)lin(-)CD45(-) very small embryonic-like stem cells (VSELs). First, to address recent controversies on Oct4 expression in cells isolated from adult organs,...
8.
Wysoczynski M, Reca R, Lee H, Wu W, Ratajczak J, Ratajczak M
Leukemia . 2009 Apr; 23(8):1455-61. PMID: 19357704
We reported that complement (C) becomes activated and cleaved in bone marrow during preconditioning for hematopoietic transplantation and the third C component (C3) cleavage fragments, C3a and (desArg)C3a, increase responsiveness...
9.
Kucia M, Wysoczynski M, Ratajczak J, Ratajczak M
Cell Tissue Res . 2007 Sep; 331(1):125-34. PMID: 17828555
Bone marrow (BM) develops in mammals by the end of the second/beginning of the third trimester of gestation and becomes a major hematopoietic organ in postnatal life. The alpha-chemokine stromal...
10.
Wysoczynski M, Kucia M, Ratajczak J, Ratajczak M
Leukemia . 2007 Mar; 21(5):973-82. PMID: 17330096
We hypothesized that the third complement component (C3) cleavage fragments (C3a and (des-Arg)C3a) are involved in stress/inflammation-related thrombocytosis, and investigated their potential role in reactive thrombocytosis induced by bleeding. We...